This one-hour, on-demand, journal article-based activity explores considerations for naloxone dosing for prevention of return to use for people with opioid use disorder. It examines the relationship between plasma levels of extended-release naltrexone (XR-NTX) and subjective responses to opioids in individuals with opioid use disorder (OUD), highlighting the importance of maintaining therapeutic naltrexone (NTX) levels. Through original research, the study underscores the clinical significance of achieving consistent blockade of opioid effects through maintaining therapeutic naltrexone (NTX) levels. It identifies factors influencing individual variability in NTX plasma levels, their impact on treatment outcomes, and offers insights for personalizing approaches in OUD management.
- Provider:American Society of Addiction Medicine
- Activity Link: https://elearning.asam.org/products/clinical-implications-of-the-relationship-between-naltrexone-plasma-levels-and-the-subjective-effects-of-heroin-in-humans
- Start Date: 2024-03-12 05:00:00
- End Date: 2024-03-12 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Journal-based CE
- CME Finder Type: Other
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Critical Care Medicine, General Pediatrics, Hospital Medicine, Internal Medicine, Medical Toxicology, Pediatric Critical Care Medicine